Financhill
Back

Moleculin Biotech Vs. Cara Therapeutics Industry Stock Comparison

Sell
29

MBRX
Moleculin Biotech

Last Price:
2.34
Seasonality Move:
-2.49%
Sell
40

CARA
Cara Therapeutics

Last Price:
0.32
Seasonality Move:
5.28%
Sell
29
Moleculin Biotech (MBRX) is a Sell

Is Moleculin Biotech a Buy, Sell or Hold?

  • The current Moleculin Biotech [MBRX] share price is $2.44. The Score for MBRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • MBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Cara Therapeutics (CARA) is a Sell

Is Cara Therapeutics a Buy, Sell or Hold?

  • The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CARA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MBRX Stock Price Chart

What is Moleculin Biotech's stock price today?

  • The Moleculin Biotech share price today is $2.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CARA Stock Price Chart

What is Cara Therapeutics's stock price today?

  • The Cara Therapeutics share price today is $0.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing slight selling pressure.

MBRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.52 Sell
Chaikin Money Flow: 3384 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.61) Sell
Bollinger Bands (100): (2.24 - 3.54) Sell

CARA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 54.9 Buy
Chaikin Money Flow: -44360 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.25 - 0.29) Buy
Bollinger Bands (100): (0.27 - 0.35) Sell

MBRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.54 Sell
20-day SMA: 2.51 Sell
50-day SMA: 2.5 Sell
200-day SMA: 4.57 Sell
8-day EMA: 2.51 Sell
20-day EMA: 2.52 Sell
50-day EMA: 2.61 Sell
200-day EMA: 4.52 Sell

CARA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.29 Buy
20-day SMA: 0.27 Buy
50-day SMA: 0.29 Buy
200-day SMA: 0.53 Sell
8-day EMA: 0.29 Buy
20-day EMA: 0.28 Buy
50-day EMA: 0.3 Sell
200-day EMA: 0.75 Sell

Moleculin Biotech Earnings Growth & MBRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.

Cara Therapeutics Earnings Growth & CARA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.

Moleculin Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):